People with severe mental illnesses are far more likely to be infected with Hepatitis C virus compared to the general population, however, they often do not get treatment for their liver disease because current antiviral therapies have known psychiatric side effects.
“Against this epidemiological background, the article by Schaefer and colleagues, Hepatitis C treatment in psychiatric risk patients, represents an important study in the field,” write Sanjeev Arora and Cynthia Geppert, in the December issue of
Hepatology, a journal published by John Wiley & Sons on behalf of the American Association for the Study of Liver Diseases (AASLD). Their editorial is also available online at Wiley Interscience.
“It provides an even stronger empirical foundation for the findings of other less methodologically rigorous studies showing that patients with HCV and comorbid psychiatric and substance use disorders have comparable sustained viral responses (SVR) and rates of depression when treated with antiviral therapies,” Arora and Geppert report.
While the National Institutes of Health once advised doctors against treating HCV-infected patients who continued to use illicit drugs, drink alcohol, or who had a psychiatric history, in 2002, the agency released a statement that said “efforts should be made to increase the availability of the best current treatments” to those patients.
Research has shown this approach to be feasible and effective, and it also has important implications for public health. Still, doctors have been slow to act on the recommendation.
Arora and Geppert applaud Shaefer et. al’s work with very difficult to treat patients and point out that the key to their success was the use of a multidisciplinary team. “The patients in this study were carefully screened and monitored and received extensive education and counseling,” they point out. They also praise the work because it assessed both depressive and psychotic symptoms and demonstrates that neither diagnosis adversely affected SVR or outcome. Instead, the study adds to the growing body of evidence that shows using anti-depressant agents prior to and during HCV treatment can lessen, or even prevent, depressive reactions.
While Arora and Geppert point out that the small sample size in Schaefer et. al’s study means that the conclusion that there is no difference in SVR between controls and patients with mental health diagnosis is stronger than the data can support, they praise the forward-thinking nature of the work.
“The value of Schaefer et al.’s work is precisely in contributing to the growing body of data that challenge hepatologists and mental health professionals to develop new medications and innovative programs that can further widen the door to admit these patients to HCV treatment,” the authors conclude.
Related link:
http://www.interscience.wiley.com/journal/hepatology
Source: Wiley-Blackwell
Related stories:
Has a new era of reinstitutionalization in mental health care begun?
Research paper: A retrospective analysis of hospital episode statistics, involuntary admissions under the Mental Health Act 1983, and the number of psychiatric beds in England 1996-2006
The number of compulsory admissions to inpatient psychiatric care has increased dramatically but the number of NHS beds has fallen, and there has also been a significant increase in the number of patients admitted for alcohol and drug problems, finds a study published today on bmj.com.
End-of-life discussions with physicians may have benefits for patients and caregivers
Terminally ill patients who had end-of-life discussions with physicians were not more likely to experience emotional distress, received less aggressive medical care in their final week of life and had a better quality of life near death, compared to patients who did not have these discussions, according to a study in the October 8 issue of
JAMA.
Lawmakers make a final push for mental health bill
(AP) -- Solving the nation's economic crisis may also help Americans struggling with getting treatment for mental illness. These patients often face an added burden: limited insurance coverage compared with people whose ills are physical. The massive economic bill coming before the House addresses that problem.
Heart patients should be screened for depression
(AP) -- Heart patients should be regularly screened for signs of depression, the American Heart Association recommended Monday.
No longer depressed, or on meds
Henry Quant was just 5 years old and bedridden with chronic fevers when he began taking pills for anxiety and depression. His mother knew that the drugs helped, but they made her nervous.
An ethical argument: Include pregnant women in research
Why aren't pregnant women included in most clinical trials? That's the question posed by leading bioethicists at Duke University Medical Center, Johns Hopkins and Georgetown Universities, who say it's time to confront the challenges that have led to the exclusion of pregnant women from important research that could positively impact maternal and fetal health.
Inflammatory response to infection and injury may worsen dementia
Inflammation in the brain resulting from infection or injury may accelerate the progress of dementia, research funded by the Wellcome Trust suggests. The findings, published this week in the journal
Biological Psychiatry, may have implications for the treatment and care of those living with dementia.
Deep brain stimulation offers hope to people with treatment-resistant illnesses
Every day during a four-year deep depression, Sean Miller thought of ending his life. Nothing relieved the emotional darkness - not therapy, not medication, not loving attention from family and friends.